LGM expands its services for section 503B APIs 15-Jul-2019 By Vassia Barba LGM expands its service offerings to further support companies that supply APIs to compounding pharmacies under the FDA’s 503B section.
Update Piramal boosts HPAPI site in Michigan, US 11-Oct-2017 By Flora Southey Piramal Pharma Solutions will expand its high potency active pharmaceutical ingredient (HPAPI) capabilities at its Riverview site in Michigan, US.
Tetraphase hires Patheon to make its synthetic antibiotic eravacycline 22-Jun-2017 By Gareth Macdonald Tetraphase Pharmaceutical has hired Patheon UK Limited to make and test the synthetic antibiotic eravacycline.
Shasun Plant Gets Third Regulatory Thumbs Up in As Many Months 03-Sep-2013 By Gareth Macdonald The UK MHRA has given Shansun Pharmaceutical’s drug formulation plant in Puducherry, India a clean bill of health after an inspection last month.
SAFC showcases HPAPI handling capabilities 30-Oct-2008 By Gareth Macdonald SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.
Hovione makes latest investment in China Hovione makes latest investment in China 10-Mar-2008 By Kirsty Barnes Portugal's Hovione has become the latest in a spate of pharma industry players to invest further in China.
